Recombivax HB, Hepatitis B Vaccine (Recombinant) Pediatric Formulation, 0.5 mL
Object Details
- Merck Sharp and Dohme
- Description (Brief)
- Recombivax HB is a vaccine that provides immunization against hepatitis B. It is injected intramuscularly. Recombivax HB is the first recombinant vaccine. Prior hepatitis B vaccines relied on viruses derived from human blood sources.
- Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for the hepatitis B virus's surface antigen are inserted into yeast. Yeast produce the hepatitis B surface antigens, which are harvested and used as the active ingredient in Recombivax HB. Surface antigens are the part of the hepatitis B virus that the body recognizes to create an immune response. After being exposed to the antigen, the body learns to identify and respond quickly to the presence of hepatitis B and can successfully ward off future possible infections.
- Object consists of a white cardboard box with light blue stripes and light blue, red, and black printing. Box contains a product insert and a round clear glass bottle with metal top and white label. Bottle contains clear solution.
- Location
- Currently not on view
- ca 1988
- product expiration date
- 1988-05-14
- ID Number
- 1987.0782.01
- accession number
- 1987.0782
- catalog number
- 1987.0782.01
- Object Name
- biological
- vaccine, hepatitis
- Physical Description
- Hepatitis B surface antigen on alum adjuvant, 5 mcg (drug active ingredients)
- Measurements
- overall: 2 1/2 in x 1 5/16 in x 1 3/16 in; 6.35 cm x 3.33375 cm x 3.01625 cm
- bottle: 3.3 mm x 1.4 cm; 1/8 in x 9/16 in
- place made
- United States: Pennsylvania, West Point
- See more items in
- Medicine and Science: Medicine
- Health & Medicine
- The Antibody Initiative
- Biotechnology and Genetics
- Antibody Initiative: Infectious Disease, Allergy, and Immunotherapy Collections
- Recombinant Pharmaceuticals
- Science & Mathematics
- National Museum of American History
- Subject
- Vaccines
- Record ID
- nmah_1000962
- Metadata Usage (text)
- CC0
- GUID (Link to Original Record)
- https://n2t.net/ark:/65665/ng49ca746a8-613f-704b-e053-15f76fa0b4fa
Related Content
There are restrictions for re-using this image. For more information, visit the Smithsonian's Terms of Use page .
International media Interoperability Framework
IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more.